Jci_page_head_homepage_01 Jci_page_head_homepage_02
R. Gisli Jenkins, Xiao Su, George Su, Christopher J. Scotton, Eric Camerer, Geoffrey J. Laurent, George E. Davis, Rachel C. Chambers, Michael A. Matthay, Dean Sheppard
Published in Volume 116, Issue 6
J Clin Invest. 2006; 116(6):1606–1614 doi:10.1172/JCI27183
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6
PAR1-induced pulmonary edema is mediated by the αv β6 integrin.

(A) Mice were pretreated with control nonblocking antibody (white bars) or αvβ6 blocking antibody (black bars) before ventilation at 24 ml/kg and intratracheal instillation with PAR1-specific peptide (TFLLRN), vehicle (HBSS), or peptide control (FTLLRN). ELW was measured as the wet-to-dry weight ratio of excised lungs. (B) Mice were pretreated with control nonblocking antibody (white bars) or αvβ6 blocking antibody (black bars) before ventilation at 24 ml/kg and intratracheal instillation of peptide and controls. Lung extravascular plasma equivalents were calculated based on the extravasation of 125I-labeled albumin into the lungs. Hank’s, n = 8; TFLLRN, n = 10; and FTLLRN, n = 11. Values are presented as mean + SEM. *P < 0.01.